Skip Navigation LinksHome > August 15, 2013 - Volume 63 - Issue 5 > Dual Therapy With Lamivudine + Protease Inhibitor During Pre...
JAIDS Journal of Acquired Immune Deficiency Syndromes:
doi: 10.1097/QAI.0b013e31829b2c4b
Letters to the Editor

Dual Therapy With Lamivudine + Protease Inhibitor During Pregnancy for Prevention of Mother-to-Child Transmission of HIV-1

Gliga, Smaranda S.*,†; Clavel, Cyril O.; Alix, Anne F.; Dommergues, Marc A.; Quetin, Frederique§; Marcelin, Anne G.‖,¶; Schneider, Luminita¶,#; Stitou, Hind¶,#; Calin, Ruxandra¶,#; Caby, Fabienne¶,#; Valantin, Marc A.¶,#; Katlama, Christine¶,#; Tubiana, Roland¶,#

Erratum

Erratum

In the article by Gliga et al, appearing in JAIDS: Journal of Acquired Immune Deficiency Syndromes, Vol. 63, No. 5, pp. e159-e163 entitled “Dual Therapy With Lamivudine + Protease Inhibitor During Pregnancy for Prevention of Mother-to-Child Transmission of HIV-1”, the author Marc A. Dommergues should appear as Marc Dommergues.

JAIDS Journal of Acquired Immune Deficiency Syndromes. 66(1):e30, May 1, 2014.

Login